Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Basal Cell Cancer
Research results from L.L. Lopes and co-authors update knowledge of basal cell cancer
July 1st, 2008
" Basal cell carcinoma (BCC) is the most frequent non-melanoma skin cancer. Curettage and electrosurgery is probably the method most commonly used by dermatologists for the treatment of small and low risk BCCs," scientists in Teresina, Brazil report. "However, one is unable to determine the persistence of any residual tumor. This study was carried out in order to demonstrate the presence of such tumoral cells after curettage and electrofulguration. Methods 20 primary BCC outpatients were studied at the Dermatology Service of Getulio Vargas Hospital in the city of Teresina - State of Piaui - Brazil, with lesions of up to 1 cm in diameter on the face, and up to 1.5 cm...
Source: Cancer Weekly (2008-07-01)
|
